Nutritional supplement for weight loss in lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether a nutritional drink with L-carnitine can help people with lung cancer who are losing weight (cachexia) gain or maintain weight while on chemotherapy. L-carnitine may help the body use food better and reduce muscle loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer.
- You are losing weight (more than 5% in the last 6 months, or more than 2% with low BMI or muscle loss).
- You are 18 years or older.
- You are planning to have or are currently having chemotherapy.
- Your doctor thinks you are likely to live at least 3 more months.
- You have adequate kidney, liver, and blood cell counts as determined by your doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new form of megestrol, a medicine that helps stimulate appetite and promote weight gain, in people with advanced non-small cell lung cancer who are starting their first chemotherapy and are at risk of malnutrition. The goal is to see if it improves nutrition and overall well-being during treatment.
This trial tests a treatment called postbiotics (which are helpful byproducts from good bacteria) to see if they can help reduce weight loss and muscle wasting in people with advanced lung cancer. If you have this type of cancer and have been losing weight, this study might offer a way to help you feel stronger and improve your quality of life.
This trial tests whether providing extra nutritional support to people with advanced lung cancer before they start their first chemotherapy or other treatment can improve their health. The goal is to see if good nutrition helps patients tolerate treatment better and maintain their strength.
This study tests whether a drug already approved for other cancers can help patients with advanced lung, pancreatic, or colorectal cancer who are losing weight. The drug may help improve appetite and weight stability.
This study looks at different types of weight loss (cachexia) in people with advanced lung, pancreatic, or colorectal cancer. Researchers want to find patterns to better understand and treat it. You can join even if you haven't lost weight yet.
This study tests whether adding a drug that boosts appetite and weight to standard lung cancer treatment helps people with advanced small cell lung cancer who are experiencing weight loss and poor appetite. It aims to improve quality of life and treatment outcomes.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.